Business · 06/08/2002
FDA Amends Animal Drug Regulations Due to Endo Pharmaceuticals' Address Change
The US Food and Drug Administration (FDA) has updated its animal drug regulations to account for a recent change in the address of Endo Pharmaceuticals, Inc., a leading pharmaceutical company.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →